Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

LH

Navigating the Stock Market – Key Insights

Laboratory logged a -0.4% change during today's morning session, and is now trading at a price of $266.56 per share. The S&P 500 index moved 0.0%. LH's trading volume is 59,364 compared to the stock's average volume of 794,727.

Laboratory trades -6.62% away from its average analyst target price of $285.45 per share. The 18 analysts following the stock have set target prices ranging from $260.0 to $323.0, and on average have given Laboratory a rating of buy.

If you are considering an investment in LH, you'll want to know the following:

  • Laboratory's current price is 93.5% above its Graham number of $137.75, which implies that at its current valuation it does not offer a margin of safety

  • Laboratory has moved 26.9% over the last year, and the S&P 500 logged a change of 16.6%

  • Based on its trailing earnings per share of 9.07, Laboratory has a trailing 12 month Price to Earnings (P/E) ratio of 29.4 while the S&P 500 average is 29.3

  • LH has a forward P/E ratio of 16.6 based on its forward 12 month price to earnings (EPS) of $16.02 per share

  • Its Price to Book (P/B) ratio is 2.61 compared to its sector average of 3.19

  • Labcorp Holdings Inc. provides laboratory services.

  • Based in Burlington, the company has 60,900 full time employees and a market cap of $22.1 Billion. Laboratory currently returns an annual dividend yield of 0.5%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS